Compliance Report · Cosmetics & Personal Care
Body Lotion / Moisturizing Cream
Where shipments fail
Ranked by how often we see it-
01 Most common
Undeclared or banned skin-lightening actives. Any brightening, whitening
This is the specific defect behind Kenya's public recall of hundreds of skin-lightening products.
-
02 Second
Preservative efficacy: body lotion is a water-based emulsion shipped and stored across a long
-
03 Third
PH drift is common on formulations developed for a different regional market and never re-validated locally
Body lotion is expected to sit close to skin's natural mantle, and a product that tests meaningfully outside that band is flagged as an irritancy risk even before any claim.
Applicable Standard: KS 580:2014 (KEBS) — Cosmetic Creams, Lotions and Gels for Skin Care — Specification
Body lotion and moisturizing cream are the highest-volume line item in almost every cosmetics shipment we review, and it is precisely because the category feels so familiar that importers most often assume it needs no real compliance work before it ships. That assumption is wrong on two counts. First, KS 580:2014 sets binding physicochemical and microbiological limits for creams, lotions and gels — it is not a voluntary quality guideline, it is the specification KEBS-approved laboratories test against at the point of entry. Second, anything KS 580:2014 does not cover directly falls back to the general cosmetic safety standard, KS 2937:2021, and to KS EAS 346 for labelling, which means a compliant lotion has to satisfy two overlapping frameworks at once rather than a single checklist. Kenya has also become considerably more aggressive in inspecting this exact category following a wave of recalled skin-lightening lotions found to contain banned actives, which means brightening or whitening claims now draw a level of scrutiny that plain moisturizers did not attract five years ago.
Why This Category Gets Flagged
The most consequential issue is undeclared or banned skin-lightening actives. Any brightening, whitening, or “even-tone” claim on a body lotion triggers targeted screening for hydroquinone above the permitted concentration, corticosteroids, and mercury compounds, regardless of what the printed ingredient list states — this is the specific defect behind Kenya’s public recall of hundreds of skin-lightening products, and inspectors now treat the claim itself as a trigger for testing rather than waiting for a complaint. The second issue is preservative efficacy: body lotion is a water-based emulsion shipped and stored across a long, often uncontrolled temperature chain, and a preservative system that passes challenge testing at the point of manufacture can still fail by the time the product reaches a Kenyan shelf if it was never validated against tropical storage conditions in the first place. Third, pH drift is common on formulations developed for a different regional market and never re-validated locally — body lotion is expected to sit close to skin’s natural mantle, and a product that tests meaningfully outside that band is flagged as an irritancy risk even before any claim is examined. Fourth, and increasingly common, is an “with SPF” or “sun protection” phrase added to what is otherwise a standard body lotion without the manufacturer running the full sunscreen-specific assessment a dedicated SPF product requires — the moment a numeric SPF value or a sun-protection claim appears anywhere on the pack, the product is assessed against the same claim-substantiation standard a dedicated sunscreen would face, regardless of how the rest of the formulation is positioned.
Test Parameters
| Parameter | Test Method / Basis | Requirement or Limit |
|---|---|---|
| pH | KS 580:2014 | Typically 4.5–7.0, close to skin’s natural pH |
| Viscosity / consistency | KS 580:2014 | Within declared range; no phase separation |
| Preservative efficacy (challenge test) | KS ISO 11930 | Pass — no microbial regrowth across the test period |
| Total viable microbial count | KS ISO 16212 | ≤ 1,000 cfu/g; absence of E. coli, S. aureus, P. aeruginosa |
| Heavy metals (lead, arsenic, mercury) | KS 2937:2021 general cosmetic limits | Lead ≤ 20 ppm; Arsenic ≤ 3 ppm; Mercury not detected (banned) |
| Skin-lightening actives screening | Applied where any whitening/brightening claim is present | Hydroquinone, corticosteroids and mercury compounds not permitted |
| Net content verification | Declared vs. actual fill | Within standard fill-tolerance of declared weight/volume |
Labeling Requirements
The label must show the product name, a full INCI-format ingredient list in descending concentration order, net content in metric units, a batch or lot number, manufacture and expiry dates (or a period-after-opening symbol), storage instructions, usage directions, and country of origin, in English and/or Kiswahili. Any functional claim — “anti-aging”, “whitening”, “brightening”, “dermatologically tested”, “hypoallergenic” — is treated as a testable statement rather than marketing language: KEBS can request the substantiation file behind it, and a whitening or brightening claim specifically triggers the actives screening described above whether or not the label discloses the active responsible. Products making no functional claim at all still need the standard INCI disclosure; the common mistake is printing an ingredient list built around trade names or a different market’s naming convention instead of standard INCI terms. Where a product carries both a whitening claim and a fragrance, both disclosures are checked independently — a compliant INCI list does not by itself satisfy the separate actives-substantiation requirement triggered by the whitening claim, and treating the two as one checklist item is the most common way this section gets shortchanged.
Packaging & Documentation
A Certificate of Conformity is issued following KEBS conformity assessment, and the route applied — document review only, document review plus sampling, or full physical inspection and testing — depends on a risk assessment carried out on receipt of the certification request. A first-time importer, a product carrying a whitening or brightening claim, or a shipment with incomplete documentation is routed toward the more intensive end of that scale almost automatically, which is exactly why the documentation below is worth assembling before the request is filed rather than in response to a query from the contractor.
| Document | Purpose / When Required |
|---|---|
| Certificate of Analysis | From an accredited lab, confirming pH, preservative efficacy, microbial limits and heavy metals |
| Certificate of Free Sale | Confirms lawful sale in the country of origin; expected for first-time importers |
| Certificate of Conformity | KEBS conformity assessment and clearance document for every consignment |
| Claims substantiation dossier | Supporting evidence for any functional claim — whitening, anti-aging, dermatologically tested |
| PPB clearance | Required only if wording crosses into therapeutic territory (e.g. “treats eczema”) |
| KEBS Diamond Mark (optional) | Voluntary premium quality mark that increases retailer and distributor confidence |
Typical Gaps We Find
Preservative systems under-dosed for tropical storage conditions are the most common technical failure we see in this category, usually surfacing only once a shipment has already spent weeks in transit. Close behind is whitening or brightening language used without disclosing the active responsible for the effect — sometimes because the active itself is undeclared, which is the defect regulators treat most seriously given the recent recall history. INCI ingredient lists built around trade names rather than standard nomenclature round out the recurring list, along with missing Certificates of Analysis on first shipments from a new manufacturer. None of these require reformulating a well-made lotion — they require the documentation and label review to happen before the container leaves origin, not after it is held at the port. Taken together, these are almost never grounds to reject a well-made lotion outright — they’re gaps that show up because the compliance file wasn’t assembled with the same care as the formulation itself, and assembling it before the shipment leaves origin is materially cheaper than resolving it after a hold notice arrives.
